Warner (India) Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 19.13%
- Profit Growth -18.69%
- Ebitda 126.29%
- Net Worth 53.58%
- Total Assets 42.98%
About Warner (India) Pharma
Warner (India) Pharma Private Limited (WIPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 December 2007 and has a history of 17 years and two months. Its registered office is in North West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gyanesh Jeswal, Ashutosh Goel, and Mayank Goel serve as directors at the Company.
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85191DL2007PTC171397
- Company No.
171397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Warner (India) Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Goel  | Director | 28-Sep-2020 | Current |
| Gyanesh Jeswal | Director | 13-Dec-2007 | Current |
| Ashutosh Goel | Director | 28-Sep-2020 | Current |
Financial Performance of Warner (India) Pharma.
Warner (India) Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.13% increase. The company also saw a substantial fall in profitability, with a 18.69% decrease in profit. The company's net worth Soared by an impressive increase of 53.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Warner (India) Pharma?
Unlock access to Warner (India) Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Recova Pharma Expo Private LimitedGyanesh Jeswal is a mutual person
Warner India Lifesciences LimitedGyanesh Jeswal is a mutual person
- Admed Overseas Private Limited
Gyanesh Jeswal and Mayank Goel are mutual person
- Prindey Travels Private Limited
Gyanesh Jeswal is a mutual person
- Palohma Healthcare Private Limited
Ashutosh Goel and Mayank Goel are mutual person
- Cogni Labs Limited
Ashutosh Goel and Mayank Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Warner (India) Pharma?
Unlock and access historical data on people associated with Warner (India) Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Warner (India) Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Warner (India) Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
